DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,365,395 | +104194.9% | 53,871 | +0.9% | 0.46% | +8.2% |
| Q2 2023 | $12,815 | -1.9% | 53,396 | +3.0% | 0.43% | -10.8% |
| Q1 2023 | $13,062 | -4.4% | 51,826 | +0.7% | 0.48% | -10.8% |
| Q4 2022 | $13,662 | -99.9% | 51,474 | +0.4% | 0.54% | -3.9% |
| Q3 2022 | $13,237,000 | +8.7% | 51,249 | +6.7% | 0.56% | +9.1% |
| Q2 2022 | $12,176,000 | +2.3% | 48,027 | +18.4% | 0.51% | +5.3% |
| Q1 2022 | $11,898,000 | -4.2% | 40,561 | +7.5% | 0.49% | -3.4% |
| Q4 2021 | $12,416,000 | +10.4% | 37,736 | +2.1% | 0.50% | -4.5% |
| Q3 2021 | $11,247,000 | +13.4% | 36,943 | -0.1% | 0.53% | +12.8% |
| Q2 2021 | $9,920,000 | +17.3% | 36,966 | -1.6% | 0.47% | +13.6% |
| Q1 2021 | $8,455,000 | -3.1% | 37,563 | -4.4% | 0.41% | -8.2% |
| Q4 2020 | $8,727,000 | +10.0% | 39,284 | +6.6% | 0.45% | -8.2% |
| Q3 2020 | $7,936,000 | +28.1% | 36,854 | +5.2% | 0.49% | +12.6% |
| Q2 2020 | $6,195,000 | +2.5% | 35,031 | -19.8% | 0.44% | +5.3% |
| Q1 2020 | $6,043,000 | +19.7% | 43,659 | +32.8% | 0.41% | +12.5% |
| Q4 2019 | $5,048,000 | +6.8% | 32,888 | +0.5% | 0.37% | -2.1% |
| Q3 2019 | $4,725,000 | -43.7% | 32,716 | -44.2% | 0.38% | +1.4% |
| Q2 2019 | $8,386,000 | +131.2% | 58,680 | +113.6% | 0.37% | +5.4% |
| Q1 2019 | $3,627,000 | +31.1% | 27,470 | +2.4% | 0.35% | +15.8% |
| Q4 2018 | $2,767,000 | -2.9% | 26,829 | +2.3% | 0.30% | +11.4% |
| Q3 2018 | $2,849,000 | +10.6% | 26,223 | +0.5% | 0.27% | +3.0% |
| Q2 2018 | $2,576,000 | -17.9% | 26,100 | -18.5% | 0.26% | -1.1% |
| Q1 2018 | $3,137,000 | -10.5% | 32,036 | -15.1% | 0.27% | +6.8% |
| Q4 2017 | $3,504,000 | +8.9% | 37,748 | +0.6% | 0.25% | +2.9% |
| Q3 2017 | $3,217,000 | -2.6% | 37,505 | -4.2% | 0.24% | -2.0% |
| Q2 2017 | $3,304,000 | -1.2% | 39,157 | +0.1% | 0.25% | -3.9% |
| Q1 2017 | $3,345,000 | -2.7% | 39,114 | -11.4% | 0.26% | +4.9% |
| Q4 2016 | $3,438,000 | -16.9% | 44,170 | -16.3% | 0.25% | -10.5% |
| Q3 2016 | $4,137,000 | -19.6% | 52,777 | +3.6% | 0.28% | -17.4% |
| Q2 2016 | $5,146,000 | -1.2% | 50,952 | -7.2% | 0.33% | +5.4% |
| Q1 2016 | $5,210,000 | +23.9% | 54,923 | +21.3% | 0.32% | +1.9% |
| Q4 2015 | $4,206,000 | +21.0% | 45,284 | +11.0% | 0.31% | +3.7% |
| Q3 2015 | $3,477,000 | -2.2% | 40,802 | -1.8% | 0.30% | +3.5% |
| Q2 2015 | $3,556,000 | +1.3% | 41,551 | +0.5% | 0.29% | +1.4% |
| Q1 2015 | $3,509,000 | -9.9% | 41,329 | -9.1% | 0.28% | -0.7% |
| Q4 2014 | $3,895,000 | +8.1% | 45,445 | -4.2% | 0.29% | +8.7% |
| Q3 2014 | $3,603,000 | -3.5% | 47,424 | -4.8% | 0.26% | -2.2% |
| Q1 2014 | $3,734,000 | -2.3% | 49,793 | +0.6% | 0.27% | -3.6% |
| Q4 2013 | $3,822,000 | +11.0% | 49,503 | -0.4% | 0.28% | +1.1% |
| Q3 2013 | $3,444,000 | – | 49,687 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |